Navigation Links
Theranostics Health Signs Research Collaboration Agreement
Date:5/15/2008

ROCKVILLE, Md., May 15 /PRNewswire/ -- Theranostics Health (THX) today announced that it has entered into a three-year master research collaboration agreement with Duke University. This relationship will provide Duke investigators access to the company's core technologies: Laser Capture Microdissection (LCM) and Reverse Phase Protein Microarray (RPMA). The proprietary combination of these technologies provides a powerful mechanism to accurately and reliably measure the aberrant protein signaling and protein molecular networks used by tumor cells obtained directly from a patient's biopsy. This information can be used to investigate patient-specific treatments and individual treatment regimens, and also, to better understand the mechanisms of tumorigenesis in order to discover and develop new, safer and more effective therapies.

According to Dr. Neil Spector, Director of Duke's Translational Research Oncology Program, "those of us at Duke who are going to participate in this umbrella agreement with Theranostics Health are excited about the insight this collaboration may provide on the use of phosphoproteomics to shed light on the complexities of the signaling networks that regulate tumor cell growth, survival, migration/invasion, and resistance to targeted therapies. We are intrigued by the possibility of applying this information to investigate more effective therapies for our patients."

"The future of cancer treatment is personalized, targeted therapies and patient stratification for clinical trials," says Dr. Emanuel Petricoin, CSO of Theranostics Health. "We believe that this research collaboration with Duke, one of the top institutions in the world, will provide an important next step for our company in both research applications at the bench as well as working together with Duke investigators during phase I, II and III clinical trials."

Dr. Danong Chen, President and CEO of Theranostics Health, is equally optimistic about the master research agreement with Duke. "We are very pleased to begin collaboration with a nationally-recognized center of excellence and believe that Duke shares our vision of shaping a new paradigm in disease management. This relationship demonstrates the value of this technology for impacting healthcare delivery."

About Theranostics Health

Theranostics Health, LLC is a privately-held company founded in 2006 and based in Rockville, MD. Its core technology is the proprietary combination of Laser Capture Microdissection (LCM) and Reverse Phase Protein Microarray (RPMA) both developed by the company's co-founders Drs. Lance Liotta and Emanuel Petricoin III. The technology measures the activity of a large number of biomarkers, enabling pharmaceutical companies to accurately profile their drug candidates to more efficiently develop safer, more effective therapeutics. More importantly, it enables physicians to tailor optimized therapies to their patients based on the biomarker profile of each individual patient, providing safer and more effective therapies. Theranostics Health is currently working with 5 of the top 10 global pharmaceutical companies in their drug R&D efforts. For more information please email info@theranosticshealth.com or visit http://www.theranosticshealth.com.


'/>"/>
SOURCE Theranostics Health, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. NIH Grants Exclusive License to Theranostics Health
2. SXC Health Solutions to present at the FBR Capital Markets 12th Annual Spring Investor Conference
3. Mergent, Inc. Announces Changes to the HealthShares(TM) Composite Index, Dermatology and Wound Care Index and Orthopedic Repair Index - Correction
4. The 2008 AMIA Spring Congress to Showcase Best Practices and Innovations in Biomedical and Health Informatics Research and Education
5. Diagnostic Health Corporation Names Robert E. Gontarek as COO
6. Vancouver Coastal Health Authority Makes Waves With Patient Flow
7. Guardian Survey: Employees Are Confused About Their Health Coverage and Have No Plans for Healthcare in Retirement
8. Healthy Farms, Healthy Schools Grant Applications Available
9. Somanetics Corporation to Present at Citigroup 2008 Healthcare Conference
10. HealthSTAR Public Relations Hires Hayley Soffer, Executive Vice President
11. IADR and GlaxoSmithKline Consumer Healthcare announce winners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... today at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra ... authored journal articles published in Emergency Medicine Practice and Pediatric Emergency ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... , Belgium , June ... MKT: VNRX), today announced the appointment of Dr. ... of Directors as a Non-Executive Director, effective June ... Company,s Audit, Compensation and Nominations and Governance Committees.  ... Dr. Futcher will provide independent expertise and strategic ...
Breaking Medicine Technology: